Innate Pharma (IPHA) SEC Filings & 10K Form

→ Exposed: 10 CENT Crypto to Explode April 20th? (From True Market Insiders) (Ad)

Free IPHA Stock Alerts

$2.37

-0.05 (-2.07%)

(As of 04/23/2024 ET)

Compare

Recent Innate Pharma SEC Filings

Filing Types

Ownership Filings

Time Frame

Start Date

End Date

Export to Excel

Date	Filer	Form Type
04/15/2024 5:02 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/15/2024 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/10/2024 5:51 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/04/2024 7:03 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 20-F Registration statement / Annual report / Transition report
03/21/2024 8:20 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/21/2024 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/19/2024 5:33 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
Get the Latest News and Ratings for IPHA and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Innate Pharma and its competitors with MarketBeat's FREE daily newsletter.
03/14/2024 6:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/06/2024 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
03/06/2024 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/21/2024 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
02/06/2024 4:00 PM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 424B5
02/06/2024 4:05 PM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/16/2024 11:15 PM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form EFFECT
01/12/2024 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/05/2024 5:09 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/04/2024 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
01/04/2024 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/20/2023 3:45 PM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form F-3 Registration statement for securities of certain foreign private issuers
12/20/2023 3:30 PM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/19/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/18/2023 10:40 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/11/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
12/11/2023 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/27/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/14/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/07/2023 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
11/03/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/27/2023 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/19/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/16/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/10/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
10/05/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/22/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/14/2023 5:27 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
09/14/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/29/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
08/10/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/11/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
07/07/2023 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/26/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
Exposed: 10 CENT Crypto to Explode April 20th? (Ad) Former Wall Street Insider and Professional Money Manager Reveals 4 Cryptos BETTER Than Bitcoin Click For My #1 FREE Crypto for 2024
06/16/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/12/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/12/2023 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/08/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
06/07/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/26/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/23/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/10/2023 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/09/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/03/2023 5:00 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
05/03/2023 5:01 AM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934
04/26/2023 3:01 PM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 424B5
04/26/2023 3:02 PM	Innate Pharma SA (Filer) Innate Pharma (Filer)	Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934

(Data available from 1/1/2016 forward)

Related Companies and Tools

Related Companies:

SEC Filings Tools:

This page (NASDAQ:IPHA) was last updated on 4/23/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Innate Pharma (IPHA) SEC Filings & 10K Form

Recent Innate Pharma SEC Filings

Related Companies and Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info